Evaluation of Predictive Proteic Profile on Mortality in the Acute Phase of Septic Shock in Cancer Patients
18 Years
N/A
Both
Sepsis, Septic Shock, Cancer
Trial Information
Evaluation of Predictive Proteic Profile on Mortality in the Acute Phase of Septic Shock in Cancer Patients
Method: Monocentric prospective study with diagnostic and prognostic expectations.
Primary objective:
Identification and characterization of early proteic biomarkers predictive of short term
mortality in cancer patients with septic shock.
Secondary objective:
Research of clinical and biological prognostic factors.
Inclusion Criteria:
- Patient from oncology or hematology with a septic shock
- Patient aged 18 years and older
- Inclusion within the 24 hours of the septic shock in the intensive care unit
- Signed consent according to the emergency reglementation
Exclusion Criteria:
- Pregnancy, breast feeding
- Patient with decision of care limitation
- Patient with legal protection
Type of Study:
Interventional
Study Design:
Intervention Model: Single Group Assignment, Masking: Open Label
Outcome Measure:
Identification and characterization of early proteic biomarkers predictive of short term mortality in cancer patients with septic shock.
Outcome Time Frame:
1 month
Safety Issue:
No
Principal Investigator
Djamel MOKART, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Institut Paoli-Calmettes
Authority:
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study ID:
PROTEOHSEPS/IPC 2005-011
NCT ID:
NCT00930085
Start Date:
August 2008
Completion Date:
May 2011
Related Keywords:
- Sepsis
- Septic Shock
- Cancer
- sepsis
- septic shock
- Sepsis
- Shock
- Shock, Septic
Name | Location |
|---|
